FDA authorizes Pfizer’s Covid omicron booster as fourth shot for kids under 5

FDA authorizes Pfizer’s Covid omicron booster as fourth shot for kids under 5

“Children six months through four years old who completed their three-dose primary series with Pfizer and BioNTech’s original monovalent shots more than two months ago are now eligible to receive a single booster dose of the updated shot.”

Pfizer’s primary series for young children consists of three doses, while rival drugmaker Moderna’s primary series for that same age group is only two.

Since December, children in that age group who completed two doses of Pfizer’s original vaccine have been eligible to receive the omicron booster as their third shot, or last dose in their primary series. 

The agency noted that children who received the omicron shot as their third dose aren’t eligible for the bivalent booster right now, but they should still be protected against a severe case of Covid.

“Today’s authorization provides parents and caregivers of children 6 months through 4 years of age who received the three-dose primary series with the monovalent Pfizer-BioNTech COVID-19 Vaccine an opportunity to update their children’s protection by receiving a booster dose with the Pfizer-BioNTech COVID-19 Vaccine, Bivalent,” Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.

Full Link ( Here )

© CopyRights RawNews1st